| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/02/2004 | DE19910682B4 Verwendung eines Kombinationspräparates zur Therapie einer Fibrat-induzierten Hyperhomocysteinämie The use of a combination product for the treatment of a fibrate-induced hyperhomocysteinemia |
| 09/02/2004 | DE10258007A1 Neue aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New aromatic Fluorglycosidderivate, pharmaceutical compositions containing them and their use |
| 09/02/2004 | CA2518313A1 Medicament comprising noble metal fineparticles |
| 09/02/2004 | CA2518311A1 Superoxide anion scavenger |
| 09/02/2004 | CA2515480A1 Use of acylated aminopropanediols and sulphur and nitrogen analogues of same for different therapeutic applications |
| 09/02/2004 | CA2514472A1 Sulfonamide substituted xanthine derivatives for use as pepck inhibitors |
| 09/01/2004 | EP1452530A1 Azole compound and medicinal use thereof |
| 09/01/2004 | EP1452528A1 Xanthine oxidase inhibitors |
| 09/01/2004 | EP1452526A1 Indole compound and medicinal use thereof |
| 09/01/2004 | EP1452521A1 Cyclic compound and ppar agonist |
| 09/01/2004 | EP1452181A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 09/01/2004 | EP1452180A1 Stanol composition and the use thereof |
| 09/01/2004 | EP1452178A1 Persistent filmy preparation for topical administration containing prostaglandin derivative |
| 09/01/2004 | EP1452176A1 Insulin resistance improving agents |
| 09/01/2004 | EP1452174A1 METHOD OF STABILIZING REDUCED COENZYME Q sb 10 /sb |
| 09/01/2004 | EP1452096A1 Method of fattening poultry |
| 09/01/2004 | EP1451577A2 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases |
| 09/01/2004 | EP1451369A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 09/01/2004 | EP1451308A2 Therapeutic use of aziridino compounds |
| 09/01/2004 | EP1451210A2 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451202A1 Aryl fused azapolycyclic compounds |
| 09/01/2004 | EP1451192A1 Novel crystalline compound |
| 09/01/2004 | EP1451184A1 Dimeric compounds and their use as anti-viral agents |
| 09/01/2004 | EP1451177A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 09/01/2004 | EP1451172A1 Therapeutic isoquinoline compounds |
| 09/01/2004 | EP1451166A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 09/01/2004 | EP1451165A1 Substituted benzoxazoles and analogues as estrogenic agents |
| 09/01/2004 | EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1451156A1 4-aminoquinoline compounds |
| 09/01/2004 | EP1451153A1 Nk1 antagonists |
| 09/01/2004 | EP1450852A2 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 09/01/2004 | EP1450842A2 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 09/01/2004 | EP1450834A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 09/01/2004 | EP1450816A2 Method of treating disorder related to high cholesterol concentration |
| 09/01/2004 | EP1450806A1 Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake |
| 09/01/2004 | EP1450801A2 2-aminoquinoline compounds |
| 09/01/2004 | EP1450794A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents |
| 09/01/2004 | EP1450793A2 Hypertonia treatment during the acute phase of a cerebrovascular accident |
| 09/01/2004 | EP1450786A1 Isoflavone concentrate and method for production thereof |
| 09/01/2004 | EP1450780A1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 09/01/2004 | EP1450779A1 Method for treating autoimmune diseases |
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 09/01/2004 | EP1450750A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 09/01/2004 | EP1450629A1 Solid and stable creatine/citric acid composition(s) and compositions containing carbohydrate(s) or hydrates thereof, method for the production and use thereof |
| 09/01/2004 | EP1450610A2 Probiotic compositions |
| 09/01/2004 | EP1274675B1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 09/01/2004 | EP1194138A4 Nutritional supplements |
| 09/01/2004 | EP1165135B1 Methods of screening for compounds modulating fxr receptors |
| 09/01/2004 | EP1123008A4 Preparation and use of solidified oils |
| 09/01/2004 | EP0978278B1 4,5-dihydroxy-2-cyclopenten-1-one for the treatment of diabetes mellitus |
| 09/01/2004 | EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/01/2004 | CN1525972A Hetero-bicyclic crf antagonists |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525858A A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent for modulating cholinergic function |
| 09/01/2004 | CN1524864A Bis phosphate, preparation and uses of its pharmaceutical preparations |
| 09/01/2004 | CN1524857A Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 09/01/2004 | CN1524854A Thiazolidine diketone derivatives, preparing process and application of pharmaceutical preparations of the same |
| 09/01/2004 | CN1524572A Blood sugar and blood lipoid reducing products prepared by use of coprinus and production method thereof |
| 09/01/2004 | CN1524570A Chinese medicine for treating diabetes and preparation method therefor |
| 09/01/2004 | CN1524554A Anredera cordifolia(Ten.)Sreenis electuary and its preparation method |
| 09/01/2004 | CN1524543A Medicament formulation for preventing and treating diabetes complication and preparation method therefor |
| 09/01/2004 | CN1524534A Polysaccharide sulphate for injection and its preparing process |
| 09/01/2004 | CN1524516A Glicetin -1 slow release microspheric preparation and its use |
| 09/01/2004 | CN1164609C Olive acid lactose conjugated material and its preparation method and use |
| 09/01/2004 | CN1164579C Thiazole and oxazole derivatives and their pharmaceutical use |
| 09/01/2004 | CN1164573C Novel alpha-amino acid compound, its preparation process and medicinal composition containing same |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 09/01/2004 | CN1164321C Medicament for treating diabetes |
| 09/01/2004 | CN1164292C Natural medicine for treating hyperlipemia and hyperglycemia diseases |
| 09/01/2004 | CN1164274C Nutritive medicine for remitting or treating pregnant woman's vomiting |
| 09/01/2004 | CN1164268C Process for preparing simvastation drip pill |
| 09/01/2004 | CN1164188C Hypoglycemic health-care tea and its preparing process |
| 08/31/2004 | US6784298 2-((3-cyclohexyl-2-(2,5-dioxo-4-(thiophen-2-yl)methylimida-zol idin-1-yl)propanoyl)amino) thiazole-4-carboxylic acid methyl ester, e.g.; antidiabetic agents; hypoglycemic agents; a glucose sensor in beta-cells and hepatocytes |
| 08/31/2004 | US6784254 Preventing reabsorption of bile acids from the intestine, decreasing lipoprotein cholesterol in the bloodstream, by oral administrating a sequester agent, crosslinked polyallylamine; better taste |
| 08/31/2004 | US6784207 Phytanic acid derivative compositions |
| 08/31/2004 | US6784205 Compounds that modulate the activity of PTP-1B and TC-PTP |
| 08/31/2004 | US6784199 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
| 08/31/2004 | US6784172 Acylation of 1,4-benzodiazepines, followed by nitrosation, reduction, imination with a cyclopentanone, cyclization, reduction and deacylation |
| 08/31/2004 | US6784171 Reaction of methyl 2-amino-4-(4-fluorophenyl)-6-isopropyl-pyrimidine-5-carboxylate with methanesulfonyl chloride in the presence of strong base, reaction of the intermediate with a methylating agent in presence of strong base |
| 08/31/2004 | CA2142358C .pi.-bond aromatic vitamin chelates |
| 08/27/2004 | CA2458001A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 08/26/2004 | WO2004072643A2 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r) |
| 08/26/2004 | WO2004072282A1 Nephropathy-associated gene |
| 08/26/2004 | WO2004072078A1 Pyrazolotriazine derivatives, methods for production and uses thereof |
| 08/26/2004 | WO2004072077A1 Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments |
| 08/26/2004 | WO2004072076A1 Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
| 08/26/2004 | WO2004072066A1 Tri(cyclo) substituted amide glucokinase activator compounds |
| 08/26/2004 | WO2004072060A1 Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof |
| 08/26/2004 | WO2004072056A1 Medicinal composition |
| 08/26/2004 | WO2004072047A1 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 08/26/2004 | WO2004072041A1 Tetrahydroquinolines as agonists of liver- x receptors |
| 08/26/2004 | WO2004072031A2 Phenylacetamides and their use as glucokinase modulators |
| 08/26/2004 | WO2004072029A2 Pyrazolopyridazines useful as inhibitors of protein kinases |
| 08/26/2004 | WO2004072025A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 08/26/2004 | WO2004072016A1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 08/26/2004 | WO2004071521A1 The use of lupin conglutin for the treatment of type ii diabetes |